Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
Shehryar R SheikhNicholas ThompsonFeride FrechManoj MalhotraLara E JehiPublished in: Epilepsia (2020)
Patients with DRE experience a significant burden and decreased quality of life. Multivariate analysis is necessary to understand the complex relationship between seizure type, frequency, and impact on health-related quality of life (HRQoL) and changes over time. Effective treatments to reduce the burden for DRE patients who experience GTC seizures continue to be needed.